Cari Berget

2.9k total citations
55 papers, 1.2k citations indexed

About

Cari Berget is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Cari Berget has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 18 papers in Genetics. Recurrent topics in Cari Berget's work include Diabetes Management and Research (51 papers), Pancreatic function and diabetes (29 papers) and Diabetes and associated disorders (18 papers). Cari Berget is often cited by papers focused on Diabetes Management and Research (51 papers), Pancreatic function and diabetes (29 papers) and Diabetes and associated disorders (18 papers). Cari Berget collaborates with scholars based in United States, United Kingdom and Germany. Cari Berget's co-authors include Gregory P. Forlenza, Laurel H. Messer, Kimberly A. Driscoll, R. Paul Wadwa, Laura Pyle, Tim Vigers, Jennifer K. Raymond, John F. Thomas, Georgeanna J. Klingensmith and Cindy Cain and has published in prestigious journals such as Diabetes, Diabetes Obesity and Metabolism and Expert Opinion on Drug Delivery.

In The Last Decade

Cari Berget

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cari Berget United States 20 1.1k 664 632 158 125 55 1.2k
Sarah J. Hanes United States 15 845 0.8× 431 0.6× 406 0.6× 199 1.3× 82 0.7× 35 969
Simone von Sengbusch Germany 16 619 0.6× 262 0.4× 362 0.6× 97 0.6× 106 0.8× 59 719
G. Todd Alonso United States 18 663 0.6× 300 0.5× 476 0.8× 88 0.6× 37 0.3× 47 805
Karin Åkesson Sweden 16 428 0.4× 223 0.3× 335 0.5× 43 0.3× 72 0.6× 49 597
Neesha Ramchandani United States 13 334 0.3× 182 0.3× 154 0.2× 64 0.4× 53 0.4× 27 453
Lora Kleis United States 9 391 0.4× 255 0.4× 238 0.4× 31 0.2× 27 0.2× 15 526
Ryan Paul New Zealand 12 332 0.3× 161 0.2× 173 0.3× 53 0.3× 12 0.1× 67 466
V. Melki France 15 914 0.8× 488 0.7× 396 0.6× 223 1.4× 3 0.0× 24 1.1k
Bettina Petersen United States 12 622 0.6× 171 0.3× 137 0.2× 120 0.8× 6 0.0× 20 777
Carol J. Levy United States 20 866 0.8× 501 0.8× 436 0.7× 37 0.2× 4 0.0× 82 1.1k

Countries citing papers authored by Cari Berget

Since Specialization
Citations

This map shows the geographic impact of Cari Berget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cari Berget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cari Berget more than expected).

Fields of papers citing papers by Cari Berget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cari Berget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cari Berget. The network helps show where Cari Berget may publish in the future.

Co-authorship network of co-authors of Cari Berget

This figure shows the co-authorship network connecting the top 25 collaborators of Cari Berget. A scholar is included among the top collaborators of Cari Berget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cari Berget. Cari Berget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berget, Cari, Francesca Annan, Torben Biester, et al.. (2025). Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe. Diabetes Obesity and Metabolism. 27(6). 2909–2919. 1 indexed citations
2.
Berget, Cari, et al.. (2025). Use of an Advanced Hybrid Closed Loop System During Marathon Running: Case Examples and Clinical Implications. Diabetes/Metabolism Research and Reviews. 41(3). e70034–e70034.
3.
Buschur, Elizabeth, Julia Reedy, Cari Berget, et al.. (2025). Mixed Methods Randomized Controlled Trial Comparing Quality of Life for Pregnant Women With Type 1 Diabetes Using Hybrid Closed-Loop to Sensor-Augmented Pump Therapy. Endocrine Practice. 31(4). 494–502. 1 indexed citations
4.
5.
Marks, Brynn E., et al.. (2024). Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved Standardization. Hormone Research in Paediatrics. 99(1). 113–121. 2 indexed citations
6.
Pyle, Laura, Gregory P. Forlenza, Lindsey Towers, et al.. (2024). Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes Technology & Therapeutics. 26(9). 626–632. 5 indexed citations
7.
Forlenza, Gregory P., Daniel J. DeSalvo, Grazia Aleppo, et al.. (2024). Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technology & Therapeutics. 26(8). 514–525. 36 indexed citations
8.
Cobry, Erin, Laura Pyle, Gregory P. Forlenza, et al.. (2024). Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions. Diabetes Technology & Therapeutics. 26(2). 119–124. 8 indexed citations
9.
Sherr, Jennifer L., Melissa J. Schoelwer, Tiago Jeronimo Dos Santos, et al.. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery. Pediatric Diabetes. 23(8). 1406–1431. 93 indexed citations
10.
Messer, Laurel H., et al.. (2021). Initiating hybrid closed loop: A program evaluation of an educator‐led Control‐IQ follow‐up at a large pediatric clinic. Pediatric Diabetes. 22(4). 586–593. 11 indexed citations
11.
Forlenza, Gregory P., Tim Vigers, Cari Berget, et al.. (2021). Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technology & Therapeutics. 24(3). 157–166. 9 indexed citations
12.
Messer, Laurel H., Cari Berget, Laura Pyle, et al.. (2021). Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technology & Therapeutics. 23(12). 837–843. 52 indexed citations
13.
Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2020). 1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).
14.
Ekhlaspour, Laya, Melissa J. Schoelwer, Gregory P. Forlenza, et al.. (2020). Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technology & Therapeutics. 23(5). 384–391. 35 indexed citations
15.
Forlenza, Gregory P., Bruce A. Buckingham, Jennifer L. Sherr, et al.. (2020). 978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).
16.
Reid, Mark W., Elizabeth A. Pyatak, Cari Berget, et al.. (2019). Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes. The Diabetes Educator. 45(4). 420–430. 46 indexed citations
17.
Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2019). Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technology & Therapeutics. 22(3). 174–184. 60 indexed citations
18.
Berget, Cari, Kimberly A. Driscoll, Samantha Lange, et al.. (2019). Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations. Contemporary Clinical Trials. 82. 60–65. 3 indexed citations
19.
Berget, Cari, Laurel H. Messer, Tim Vigers, et al.. (2019). Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system. Pediatric Diabetes. 21(2). 310–318. 98 indexed citations
20.
Berget, Cari, et al.. (2017). Team Clinic: An Innovative Group Care Model for Youth With Type 1 Diabetes—Engaging Patients and Meeting Educational Needs. The Journal for Nurse Practitioners. 13(6). e269–e272. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah J. Hanes Breakdown of academic impact, for papers by Simone von Sengbusch Breakdown of academic impact, for papers by G. Todd Alonso Breakdown of academic impact, for papers by Karin Åkesson Breakdown of academic impact, for papers by Neesha Ramchandani Breakdown of academic impact, for papers by Lora Kleis Breakdown of academic impact, for papers by Ryan Paul Breakdown of academic impact, for papers by V. Melki Breakdown of academic impact, for papers by Bettina Petersen Breakdown of academic impact, for papers by Carol J. Levy
Rankless by CCL
2026